Exodus Point Capital Management, LP Pulmonx Corp Transaction History

Exodus Point Capital Management, LP

  • $13.1 Billion
  • Q1 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
BUY
$9.88 - $14.0 $102,811 - $145,684
10,406 Added 97.35%
21,095 $218,000
Q2 2023

Aug 10, 2023
BUY
$10.78 - $13.65 $115,227 - $145,904
10,689 New
10,689 $140,000
Q4 2022

Feb 13, 2023
BUY
$4.92 - $17.35 $109,593 - $386,471
22,275 New
22,275 $188,000
Q2 2021

Aug 16, 2021
SELL
$37.61 - $48.0 $185,981 - $237,360
-4,945 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$44.0 - $67.54 $1.01 Million - $1.55 Million
-22,898 Reduced 82.24%
4,945 $226,000
Q4 2020

Feb 16, 2021
BUY
$39.31 - $69.02 $1.09 Million - $1.92 Million
27,843 New
27,843 $1.92 Million

Others Institutions Holding LUNG

# of Institutions
124
Shares Held
30.8M
Call Options Held
1.2K
Put Options Held
1.2K
View Full List

About Pulmonx Corp

LUNG Quotes by TradingView
  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email